BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31582582)

  • 1. Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options.
    Amaador K; Peeters H; Minnema MC; Nguyen TQ; Dendooven A; Vos JMI; Croockewit AJ; van de Donk NWCJ; Jacobs JFM; Wetzels JFM; Sprangers B; Abrahams AC
    Neth J Med; 2019 Sep; 77(7):243-254. PubMed ID: 31582582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of monoclonal gammopathy of renal significance.
    Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
    Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.
    Ciocchini M; Arbelbide J; Musso CG
    Int Urol Nephrol; 2017 Dec; 49(12):2171-2175. PubMed ID: 28425076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance.
    Castillo JJ; Callander NS; Baljevic M; Sborov DW; Kumar S
    Am J Hematol; 2021 Jul; 96(7):846-853. PubMed ID: 33709474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MGRS - monoclonal gammopathy of renal significance].
    Wieliczko M; Matuszkiewicz-Rowińska J
    Wiad Lek; 2017; 70(6 pt 2):1175-1178. PubMed ID: 29533908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhabdomyolysis and Acute Renal Dysfunction as Initial Manifestations of Monoclonal Gammopathy of Renal Significance.
    Gudapati P; Al-Sultani A; Parmar A; Motwani R; Fortkort P
    Cureus; 2023 Feb; 15(2):e34759. PubMed ID: 36909104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal Gammopathy of Renal Significance (MGRS): Prospects for Treatment in Integrated Chinese and Western Medicine.
    Li JP; Du YT; Li S; Rao XR
    Chin J Integr Med; 2021 Sep; 27(9):643-648. PubMed ID: 34105098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance.
    Batko K; Malyszko J; Jurczyszyn A; Vesole DH; Gertz MA; Leleu X; Suska A; Krzanowski M; Sułowicz W; Malyszko JS; Krzanowska K
    Nephrol Dial Transplant; 2019 Sep; 34(9):1440-1452. PubMed ID: 30169860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
    Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
    [No Abstract]   [Full Text] [Related]  

  • 10. Bortezomib-Based Chemotherapy with Autologous Stem Cell Transplantation for Monoclonal Gammopathy of Renal Significance: A Case Report and Literature Review.
    Huang J; Sun C; Su H; Zhang C; Xiong J
    Kidney Blood Press Res; 2019; 44(4):858-869. PubMed ID: 31352451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
    Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
    Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment.
    Karam S; Haidous M; Dalle IA; Dendooven A; Moukalled N; Van Craenenbroeck A; Bazarbachi A; Sprangers B
    Crit Rev Oncol Hematol; 2023 Mar; 183():103926. PubMed ID: 36736510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal Gammopathy.
    Klomjit N; Leung N; Fervenza F; Sethi S; Zand L
    J Am Soc Nephrol; 2020 Oct; 31(10):2400-2411. PubMed ID: 32747354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
    Midha S; Nadeem O; Selamet U
    Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
    Leung N; Bridoux F; Hutchison CA; Nasr SH; Cockwell P; Fermand JP; Dispenzieri A; Song KW; Kyle RA;
    Blood; 2012 Nov; 120(22):4292-5. PubMed ID: 23047823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors.
    Gozzetti A; Guarnieri A; Zamagni E; Zakharova E; Coriu D; Bittrich M; Pika T; Tovar N; Schutz N; Ciofini S; Peña C; Rocchi S; Rassner M; Avivi I; Waszczuk-Gajda A; Chhabra S; Usnarska-Zubkiewicz L; González-Calle V; Mateos MV; Bocchia M; Bigi F; Füllgraf H; Bhasin-Chhabra B; Gentile M; Davila J; Vesole DH; Cavo M; Thapa B; Crusoe E; Einsele H; Legiec W; Charliński G; Jurczyszyn A
    Am J Hematol; 2022 Jul; 97(7):877-884. PubMed ID: 35389534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series.
    Heybeli C; Alexander MP; Bentall AJ; Amer H; Buadi FK; Dean PG; Dingli D; Dispenzieri A; El Ters M; Gertz MA; Issa NS; Kapoor P; Kourelis T; Kukla A; Kumar S; Lacy MQ; Lorenz EC; Muchtar E; Murray DL; Nasr SH; Prieto M; Rajkumar SV; Schinstock CA; Stegall MD; Warsame R; Leung N
    Am J Kidney Dis; 2022 Feb; 79(2):202-216. PubMed ID: 34175375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Bone Marrow Biopsy Evaluation in the Workup for Monoclonal Gammopathy of Renal Significance: A Diagnosis of Exclusion.
    Metcalf BD; Huang J; Kanaan HD; Abukhaled J; Li W; Samarapungavan D; Zarouk S; Zhang PL
    Arch Pathol Lab Med; 2024 Mar; 148(3):e57-e62. PubMed ID: 37787408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients.
    Steiner N; Göbel G; Suchecki P; Prokop W; Neuwirt H; Gunsilius E
    Oncotarget; 2018 Jan; 9(2):2344-2356. PubMed ID: 29416776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Gammopathy and Its Association with Progression to Kidney Failure and Mortality in Patients with CKD.
    Sy-Go JPT; Moubarak S; Vaughan LE; Klomjit N; Viehman JK; Fervenza FC; Zand L
    Clin J Am Soc Nephrol; 2024 Mar; 19(3):319-328. PubMed ID: 37948069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.